论文部分内容阅读
本文报告了“522”对半身照射肿瘤病人白细胞的防护效果。“522”能使下半身一次800rad照射肿瘤病人的白细胞下降幅度变小和促进白细胞恢复,有利于病人的治疗。“522”的副作用主要表现为恶心、呕吐和食欲减退,但病人可以耐受。作者推荐将“522”推广应用于肿瘤病人的放射治疗。
This article reports the protective effect of “522” on leukocytes in half-length irradiated tumor patients. “522” enables the lower body an irradiation of 800rad tumor patients decreased leukopenia and promote leukocyte recovery, is conducive to the treatment of patients. Side effects of “522” are mainly nausea, vomiting and loss of appetite, but patients are tolerated. The authors recommend “522” to promote the use of cancer patients radiotherapy.